Abu Dhabi-based investment firm MGX has reaffirmed its commitment to shaping the future of artificial intelligence, reviewing its latest investments in OpenAI and Isomorphic Labs during its second board meeting of 2026.
The meeting, chaired by His Highness Sheikh Tahnoon bin Zayed Al Nahyan, focused on MGX’s rapidly expanding AI portfolio and its broader strategy of investing in technologies that are expected to transform industries ranging from healthcare and scientific research to enterprise productivity and digital infrastructure.
The discussions also underscored the UAE’s growing influence in the global AI landscape as the country continues to back some of the world’s most innovative technology companies.
MGX Deepens Investment in OpenAI
One of the key highlights of the meeting was MGX’s continued support for OpenAI, one of the world's leading artificial intelligence companies.
The board reviewed MGX’s participation as a co-lead investor in OpenAI’s recent funding round, which valued the company at $122 billion.
The investment represents:
- MGX’s fifth follow-on investment in OpenAI
- A continued vote of confidence in OpenAI’s long-term vision
- A strategic commitment to frontier AI technologies
MGX said its investment philosophy centers on supporting transformative platforms capable of creating lasting economic and societal value.
As generative AI becomes increasingly integrated into businesses and daily life, OpenAI remains one of the most influential players driving innovation across the sector.
Entering AI-Powered Healthcare Through Isomorphic Labs
The board also reviewed MGX’s participation in the $2.1 billion Series B funding round of Isomorphic Labs, marking the firm’s first major investment in AI-driven drug discovery.
Isomorphic Labs, which emerged from Alphabet and DeepMind, is developing artificial intelligence systems designed to accelerate biomedical research and transform how new medicines are discovered.
The investment reflects growing global interest in applying AI to healthcare and life sciences, particularly in areas such as:
- Drug discovery and development
- Biomedical research
- Protein modeling and molecular analysis
- Healthcare innovation
- Scientific computing
Industry experts believe AI could dramatically shorten the time required to develop new treatments, potentially revolutionizing the pharmaceutical industry over the coming decade.
Expanding Across the Global AI Ecosystem
MGX is not limiting its ambitions to a single area of artificial intelligence.
The company continues to build a diversified portfolio spanning multiple layers of the AI economy, including:
- Frontier AI models
- AI cloud infrastructure
- Hyperscale computing platforms
- Enterprise AI ecosystems
- Healthcare and scientific AI applications
The strategy reflects MGX’s belief that AI will become a foundational technology influencing nearly every major industry.
According to the company, its investments are aimed at supporting innovations that can drive:
- Human productivity
- Scientific breakthroughs
- Economic growth
- Long-term technological advancement
AI Infrastructure Capacity Set to Exceed 8GW
Beyond software and AI models, MGX is also investing heavily in the infrastructure required to power the next generation of artificial intelligence.
During the meeting, the company reviewed the rapid expansion of contracted infrastructure capacity across its portfolio.
MGX expects the combined AI infrastructure supported by its investments to exceed 8 gigawatts (GW) by the end of 2026.
This infrastructure will play a critical role in meeting the soaring demand for AI computing power worldwide, enabling:
- Large-scale AI model training
- Enterprise AI deployments
- Cloud-based AI services
- Scientific computing applications
- Next-generation data centers
The rapid expansion positions MGX as an increasingly important player in the global AI infrastructure ecosystem.
UAE Strengthens Its Position as a Global AI Hub
MGX’s latest investments also reflect the UAE’s broader ambitions to become a leading global center for artificial intelligence and emerging technologies.
Over the past few years, Abu Dhabi has accelerated investments in:
- AI research and development
- Advanced computing infrastructure
- Technology startups
- Sovereign technology partnerships
- Digital transformation initiatives
These efforts are helping the UAE attract international technology companies, researchers, and investors while building a strong foundation for a knowledge-based economy.
As AI becomes a strategic priority for governments and businesses around the world, the UAE is increasingly positioning itself as both an investor and a long-term innovation partner.
Focused on Long-Term Value Creation
MGX leadership reiterated that the company’s goal extends beyond short-term investment returns.
Its long-term strategy is centered on:
- Supporting scalable AI platforms
- Encouraging responsible AI innovation
- Expanding global AI infrastructure
- Accelerating enterprise adoption of AI
- Investing in technologies with broad societal impact
Executives noted that artificial intelligence is already reshaping industries such as healthcare, finance, manufacturing, education, and scientific research, with its influence expected to grow significantly in the coming years.
Looking Ahead
As global competition in artificial intelligence intensifies, MGX is positioning itself at the center of the transformation.
Its growing investments in companies like OpenAI and Isomorphic Labs demonstrate a clear strategy: backing technologies that not only push the boundaries of innovation but also create lasting economic and social value.
For the UAE, these investments represent more than financial commitments. They signal the country’s ambition to become a global leader in the AI era — helping shape the technologies, infrastructure, and industries that will define the future.
